Tweet
Pertuzumab is a target therapy medicine which is used for the treatment of breast cancer. The brand name of this medicine is Perjeta and it is available as a 420mg injection. Pertuzumab is a tyrosine kinase inhibitor which functions by inhibiting the human epidermal growth factor receptor-2 and it stops the cell division and growth. Pertuzumab can induce cell death in several cancerous cells. Pertuzumab 420mg Injection usually does not cause hair loss in patients however even if it does it is not permanent. Hair loss by any anticancer medication is temporary and the hair growth resumes normally once the treatment ends. For more information on Pertuzumab injection contact us.